Axa S.A. Crispr Therapeutics Ag Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $145,547 - $213,798	-2,399 Reduced 41.66%	3,359 $228,000
Q4 2023 Jul 16, 2024	BUY	$38.62 - $72.18 $92,649 - $173,159	2,399 Added 71.42%	5,758 $360,000
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $222,373 - $415,612	5,758 New	5,758 $360,000
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $4.41 Million - $7.39 Million	-112,559 Closed	0 $0
Q3 2022 Feb 14, 2023	BUY	$61.1 - $83.78 $588,942 - $807,555	9,639 Added 9.37%	112,559 $7.36 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $588,942 - $807,555	9,639 Added 9.37%	112,559 $7.36 Million
Q2 2022 Feb 14, 2023	BUY	$43.23 - $73.83 $385,179 - $657,825	8,910 Added 9.48%	102,920 $6.25 Million
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $385,179 - $657,825	8,910 Added 9.48%	102,920 $6.25 Million
Q1 2022 Feb 14, 2023	SELL	$53.19 - $79.24 $986,621 - $1.47 Million	-18,549 Reduced 16.48%	94,010 $5.9 Million
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $1.12 Million - $1.67 Million	21,101 Added 28.94%	94,010 $5.9 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $61,118 - $97,044	872 Added 1.21%	72,909 $5.53 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $1.31 Million - $1.86 Million	11,861 Added 19.71%	72,037 $8.06 Million
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $5.36 Million - $8.61 Million	53,176 Added 759.66%	60,176 $9.74 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $775,040 - $1.47 Million	7,000 New	7,000 $853,000
Q4 2018 Feb 13, 2019	SELL	$22.73 - $42.34 $115,923 - $215,934	-5,100 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$42.62 - $73.59 $217,362 - $375,309	5,100 New	5,100 $300,000

Others Institutions Holding CRSP

# of Institutions

489

Shares Held

57.9M

Call Options Held

1.09M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$321 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$304 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$121 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$120 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$120 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.16B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account